1. Home
  2. RCEL vs ECBK Comparison

RCEL vs ECBK Comparison

Compare RCEL & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • ECBK
  • Stock Information
  • Founded
  • RCEL N/A
  • ECBK 1919
  • Country
  • RCEL United States
  • ECBK United States
  • Employees
  • RCEL N/A
  • ECBK N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • ECBK Banks
  • Sector
  • RCEL Health Care
  • ECBK Finance
  • Exchange
  • RCEL Nasdaq
  • ECBK Nasdaq
  • Market Cap
  • RCEL 140.5M
  • ECBK 151.0M
  • IPO Year
  • RCEL N/A
  • ECBK N/A
  • Fundamental
  • Price
  • RCEL $5.33
  • ECBK $15.34
  • Analyst Decision
  • RCEL Strong Buy
  • ECBK
  • Analyst Count
  • RCEL 4
  • ECBK 0
  • Target Price
  • RCEL $13.75
  • ECBK N/A
  • AVG Volume (30 Days)
  • RCEL 267.6K
  • ECBK 10.3K
  • Earning Date
  • RCEL 11-06-2025
  • ECBK 10-24-2025
  • Dividend Yield
  • RCEL N/A
  • ECBK N/A
  • EPS Growth
  • RCEL N/A
  • ECBK 52.06
  • EPS
  • RCEL N/A
  • ECBK 0.64
  • Revenue
  • RCEL $74,884,000.00
  • ECBK $27,795,000.00
  • Revenue This Year
  • RCEL $22.92
  • ECBK N/A
  • Revenue Next Year
  • RCEL $37.07
  • ECBK N/A
  • P/E Ratio
  • RCEL N/A
  • ECBK $24.01
  • Revenue Growth
  • RCEL 38.32
  • ECBK 12.29
  • 52 Week Low
  • RCEL $3.60
  • ECBK $12.56
  • 52 Week High
  • RCEL $14.16
  • ECBK $17.33
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 49.55
  • ECBK 36.10
  • Support Level
  • RCEL $5.14
  • ECBK $14.99
  • Resistance Level
  • RCEL $5.61
  • ECBK $15.70
  • Average True Range (ATR)
  • RCEL 0.24
  • ECBK 0.27
  • MACD
  • RCEL -0.03
  • ECBK -0.03
  • Stochastic Oscillator
  • RCEL 41.94
  • ECBK 26.35

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About ECBK ECB Bancorp Inc.

ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.

Share on Social Networks: